Lilly Falls on Oral Obesity Pill as FDA Decision Looms
Eli Lilly stock fell about 5% as investors awaited the FDA's April decision on orforglipron. Novo Nordisk's intensifi...
No fee travel points cards often provide unique perks. Discover how these benefits can maximize your travel rewards.
19,687 articlesEli Lilly stock fell about 5% as investors awaited the FDA's April decision on orforglipron. Novo Nordisk's intensifi...
The SEC has moved to clarify which crypto assets fall under securities rules, saying that many assets—including staki...
NVIDIA has traded in a tight range for months despite strong earnings. New orders from China could lift the stock if ...
DocuSign's 2026 earnings narrative centers on ARR expansion, margin discipline, and stronger cash flow in a competiti...
Oil markets bounce as Strait of Hormuz risks flare and Beijing delays a high-stakes summit. The United States undermi...
XRP shows a modest rebound but remains below critical resistance, signaling caution rather than a breakout. The marke...
A rising fintech stock year story shows profits climbing while a major fund trims nearly $300M from its stake. The mo...
Insider stock moves can be routine or signaling. This article breaks down the facts behind ford's farley sells 6,454,...
AppLovin posted stronger-than-expected Q4 results with robust margins and a strategic pivot to e-commerce ads, while ...
A Texas federal court voided the FinCEN anti-money laundering rule for title insurers, stopping broad reporting of no...
A major fund just walked away from its Li Auto position, selling roughly $33 million worth of shares in one quarter. ...
A federal probe into Tesla's FSD system raises questions for investors about safety, costs, and stock risk. This guid...